| Issue | Title | |
| Vol 18, No 2 (2011) | Editorial | Details PDF HTML |
| M. McLean | ||
| Vol 18, No 3 (2011) | Editorial | Details PDF HTML |
| Mike McLean | ||
| Vol 15, No 2 (2008) | editorial 2_08 | Abstract PDF |
| Mike McLean | ||
| Vol 13, No 5 (2006) | Editorial 5/06 | Details PDF |
| Michael McLean | ||
| Vol 14, No 5 (2007) | Editorial 5/07 | Details PDF |
| Mike McLean | ||
| Vol 14, No 6 (2007) | Editorial 6/2007 | Details PDF |
| Mike McLean | ||
| Vol 15, No 1 (2008) | Editorial for 1/2008 | Details PDF |
| Mike McLean | ||
| Vol 13, No 4 (2006) | Editorial4_06 | Details PDF |
| Michael McLean | ||
| Vol 15, No 4 (2008) | Editorial: Integrative Oncology and an Integrative Cancer Journal | Abstract PDF |
| Stephen Sagar | ||
| Vol 13, No 3 (2006) | Editorial: Volume 13, Number 3 | Details PDF |
| Michael McLean | ||
| Vol 13, No 6 (2006) | Editorial: Volume 13, Number 6 | Details PDF |
| Michael McLean | ||
| Vol 20, No 1 (2013) | Effect of cancer on ovarian function in patients undergoing in vitro fertilization for fertility preservation: a reappraisal | Details PDF HTML |
| I. Levin, B. Almog | ||
| Vol 23, No 6 (2016) | Effect of chemotherapy on health-related quality of life among early-stage ovarian cancer survivors: a study from the population-based PROFILES registry | Abstract PDF HTML |
| C.S. Bhugwandass, J.M.A. Pijnenborg, B. Pijlman, N.P.M. Ezendam | ||
| Vol 25, No 1 (2018) | Effect of early palliative care on quality of life in patients with non-small-cell lung cancer | Abstract PDF HTML |
| H. Zhuang, Y. Ma, L. Wang, H. Zhang | ||
| Vol 19, No 3 (2012) | Effect of exercise in reducing breast and chest-wall pain in patients with breast cancer: a pilot study | Abstract PDF HTML |
| P. Wong, T. Muanza, T. Hijal, L. Masse, S. Pillay, M. Chasen, I. Lowensteyn, M. Gold, S. Grover | ||
| Vol 24, No 3 (2017) | Effect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastases | Abstract PDF HTML |
| N.W. Molla, M.M. Hassanain, Z. Fadel, L.M. Boucher, A. Madkhali, R.M. Altahan, E.A. Alrijraji, E.B. Simoneau, H. Alamri, A. Salman, Z. Gao, P.P. Metrakos | ||
| Vol 26, No 3 (2019) | Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer | Abstract PDF HTML Supplemental Material |
| P. Kosalka, C. Johnson, M. Turek, J. Sulpher, A. Law, J. Botros, S. Dent, O. Aseyev | ||
| Vol 21, No 3 (2014) | Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study | Abstract PDF HTML |
| M. Orditura, G. Galizia, N. Di Martino, E. Ancona, C. Castoro, R. Pacelli, F. Morgillo, S. Rossetti, V. Gambardella, A. Farella, M.M. Laterza, A. Ruol, A. Fabozzi, V. Napolitano, F. Iovino, E. Lieto, L. Fei, A. Renda, F. Ciardiello, F. De Vita | ||
| Vol 26, No 3 (2019) | Effectiveness of first-line treatments in metastatic squamous non-small-cell lung cancer | Abstract PDF HTML |
| B. P. Levy, J. E. Signorovitch, H. Yang, O. Patterson-Lomba, C. Q. Xiang, M. Parisi | ||
| Vol 21, No 2 (2014) | Effects of dna-dependent protein kinase inhibition by NU7026 on dna repair and cell survival in irradiated gastric cancer cell line N87 | Abstract PDF HTML |
| M.T. Niazi, G. Mok, M. Heravi, L. Lee, T. Vuong, R. Aloyz, L. Panasci, T. Muanza | ||
| Vol 26, No 1 (2019) | Effects of magnanimous therapy on coping, adjustment, and living function in advanced lung cancer | Abstract PDF HTML |
| X. Huang, A. Yan, Q. Liu, L. Wu | ||
| Vol 19, No 4 (2012) | Effects of radiation and total androgen blockade on serum hemoglobin, testosterone, and erythropoietin in patients with localized prostate cancer | Abstract PDF HTML |
| M. Golfam, R. Samant, L. Eapen, S. Malone | ||
| Vol 24, No 5 (2017) | Effects of the community-based Wellspring Cancer Exercise Program on functional and psychosocial outcomes in cancer survivors | Abstract PDF HTML |
| D. Santa Mina, D. Au, J. Brunet, J. Jones, G. Tomlinson, N. Taback, D. Field, A. Berlingeri, H. Bradley, D. Howell | ||
| Vol 23, No 1 (2016) | Effects of warm acupuncture on breast cancer–related chronic lymphedema: a randomized controlled trial | Abstract PDF HTML |
| C. Yao, Y. Xu, L. Chen, H. Jiang, C.S. Ki, J.S. Byun, W. Bian | ||
| Vol 26, No 1 (2019) | Efficacy and safety of combined androgen blockade with antiandrogen for advanced prostate cancer | Abstract PDF HTML |
| Y. Yang, R. Chen, T. Sun, L. Zhao, F. Liu, S. Ren, H. Wang, X. Lu, X. Gao, C. Xu, Y. Sun | ||
| Vol 20, No 4 (2013) | Efficacy and tolerability of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer: a retrospective analysis | Abstract PDF HTML |
| T. Qin, Z.Y. Yuan, R.J. Peng, Y.D. Zeng, Y.X. Shi, X.Y. Teng, D.G. Liu, B. Bai, S.S. Wang | ||
| Vol 24, No 3 (2017) | Efficacy of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status | Abstract PDF HTML |
| C. Bilir, S. Durak, B. Kızılkaya, I. Hacıbekiroglu, E. Nayır, H. Engin | ||
| Vol 26, No 1 (2019) | Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer | Abstract PDF HTML |
| S. Bazarbashi, A. M. Hakoun, A. M. Gad, M. A. Elshenawy, A. Aljubran, A. Alzahrani, A. Eldali | ||
| Vol 17 (2010): Optimal management of metastatic colorectal cancer with the anti-EGFR monoclonal antibodies | Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer | Abstract PDF |
| M. Fakih, R. Wong | ||
| Vol 16, No 5 (2009) | Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer | Details PDF |
| J. Gaulin, R. Kotb, E. Turcotte, G. Bérard, G. Schmutz, B. Sawan, P. Beauregard | ||
| Vol 17, No 1 (2010) | EGFR overexpression in squamous cell carcinoma of the penis | Abstract PDF |
| N. Lavens, R. Gupta, L.A. Wood | ||
| Vol 19, No 1 (2012) | EGFR tyrosine kinase inhibitors in lung cancer: make no assumptions | Abstract PDF HTML |
| B. Melosky | ||
| Vol 19, No 2 (2012) | EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer | Abstract PDF HTML |
| S. Kamel-Reid, G. Chong, D.N. Ionescu, A.M. Magliocco, A. Spatz, M. Tsao, X. Weng, S. Young, T. Zhang, D. Soulieres | ||
| Vol 25, No 5 (2018) | Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients | Abstract PDF HTML |
| Y. Sun, X. L.. Zhang, Q. F. Mao, Y. H. Liu, L. Kong, M.H. Li | ||
| Vol 16, No 2 (2009) | Electrochemotherapy of tumors | Abstract PDF |
| Marko Snoj | ||
| Vol 18, No 1 (2011) | E-Manuscript Article Summaries | Details PDF HTML |
| Various Authors | ||
| Vol 18, No 2 (2011) | E-Manuscript Article Summaries | Details PDF HTML |
| Various Authors | ||
| Vol 18, No 3 (2011) | E-Manuscript Article Summaries | Details PDF HTML |
| Various Authors | ||
| Vol 18, No 4 (2011) | E-manuscript Article Summaries | Details PDF HTML |
| Amanda Shand | ||
| Vol 18, No 5 (2011) | E-manuscript Article Summaries | Details PDF HTML |
| Various Authors | ||
| Vol 18, No 6 (2011) | E-manuscript article summaries | Abstract PDF HTML |
| Current Oncology | ||
| Vol 19, No 1 (2012) | E-manuscript Article Summaries | Abstract PDF HTML |
| Multiple Authors | ||
| Vol 19, No 2 (2012) | E-manuscript article summaries | Abstract PDF HTML |
| Various Authors | ||
| Vol 26, No 4 (2019) | Emerging therapies for the treatment of relapsed or refractory diffuse large B cell lymphoma | Abstract PDF HTML |
| P. Skrabek, S. Assouline, A. Christofides, D. MacDonald, A. Prica, R. Sangha, B. A. Matthews, L. H. Sehn | ||
| Vol 23, No 6 (2016) | Emerging therapies for the treatment of relapsed or refractory follicular lymphoma | Abstract PDF HTML |
| D. MacDonald, A. Prica, S. Assouline, A. Christofides, T. Lawrence, L.H. Sehn | ||
| Vol 18, No 4 (2011) | Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey | Abstract PDF HTML |
| S. Verma, L. Provencher, R. Dent | ||
| Vol 26, No 4 (2019) | Employment outcomes for recent Canadian radiation oncology graduates | Abstract PDF HTML |
| S. K. Loewen, R. Halperin, G. Perry, M. Mckenzie, E. Vigneault, T. Stuckless, M. Brundage | ||
| Vol 22, No 6 (2015) | Enablers and barriers in delivery of a cancer exercise program: the Canadian experience | Abstract PDF HTML |
| D. Santa Mina, A. Petrella, K.L. Currie, K. Bietola, S.M.H. Alibhai, J. Trachtenberg, P. Ritvo, A.G. Matthew | ||
| Vol 17, No 6 (2010) | Encouraging data out of the 2010 Congress of the European Society for Medical Oncology with respect to non-small-cell lung cancer | Details PDF |
| V. Hirsh | ||
| Vol 25, No 4 (2018) | Endocrine therapy for breast cancer in the primary care setting | Abstract PDF HTML |
| A. Awan, A. Esfahani | ||
| Vol 17, No 5 (2010) | Endocrine therapy for male breast cancer: rates of toxicity and adherence | Abstract PDF |
| H. Visram, F. Kanji, S. F. Dent | ||
| Vol 20, No 1 (2013) | Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement | Abstract PDF HTML |
| K.I. Pritchard, K.A. Gelmon, D. Rayson, L. Provencher, Marc Webster, D. McLeod, S. Verma | ||
| Vol 17, No 6 (2010) | Endometrioid ovarian carcinoma benefits from aromatase inhibitors: case report and literature review | Abstract PDF |
| Y. Pan, M.S. Kao | ||
| Vol 25, No 4 (2018) | Engaging cancer patients in clinical practice guideline development: a pilot study | Abstract PDF Supplemental Material HTML |
| M.C. Brouwers, M. Vukmirovic, K. Spithoff, C. Zwaal, S. McNair, N. Peek | ||
| Vol 22, No 4 (2015) | Enhancing access to cancer care for the Inuit | Abstract PDF HTML |
| P. Doering, C. DeGrasse | ||
| Vol 26, No 2 (2019) | Epidermal growth factor receptor inhibitor–induced hypomagnesemia: a survey of practice patterns among Canadian gastrointestinal medical oncologists | Abstract PDF HTML |
| T. Thangarasa, J. Gotfrit, R. A. Goodwin, P. A. Tang, M. Clemons, A. Imbulgoda, M. M. Vickers | ||
| Vol 17, No 3 (2010) | Epidermal growth factor receptor targeted therapy in stage III and IV head and neck cancer | Abstract PDF |
| C. Cripps, E. Winquist, M. C. Devries, D. Stys-Norman, R. Gilbert | ||
| Vol 25, No 4 (2018) | Erratum: Cost-effectiveness of everolimus for the treatment of advanced neuroendocrine tumours of gastrointestinal or lung origin in Canada | Abstract PDF HTML |
| A. Chua, A. Perrin, J.F. Ricci, M.P. Neary, M. Thabane | ||
| Vol 19, No 3 (2012) | Erratum: Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls | Details PDF HTML |
| J. Pereira | ||
| Vol 21, No 6 (2014) | Erratum: Salpingectomy to prevent ovarian cancer | Abstract PDF HTML |
| S.A. Narod | ||
| Vol 22, No 2 (2015) | Erratum: Tumour inflammatory response: adding fuel to the fire? | Abstract PDF HTML |
| M. Valdes, M.R. Chasen | ||
| Going Beyond Efficacy | Erythropoiesis Stimulating Agents: Benefits/Risks in Supportive Care of Cancer | Abstract PDF |
| Barbara L. Melosky | ||
| Vol 22, No 2 (2015) | Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec | Abstract PDF HTML |
| A.L. Smith, C. Bascuñana, A. Hall, A. Salman, A.Z. Andrei, A. Volenik, H. Rothenmund, D. Ferland, D. Lamoussenery, A.S. Kamath, R. Amre, D. Caglar, Z.H. Gao, D.G. Haegert, Y. Kanber, R.P. Michel, G. Omeroglu-Altinel, J. Asselah, N. Bouganim, P. Kavan, G. Arena, J. Barkun, P. Chaudhury, S. Gallinger, W.D. Foulkes, A. Omeruglu, P. Metrakos, G. Zogopoulos | ||
| Vol 18, No 5 (2011) | Establishing a multicentre clinical research network: lessons learned | Abstract PDF HTML |
| N. A. Hagen, C. R. Stiles, P. D. Biondo, G. G. Cummings, R. L. Fainsinger, D. E. Moulin, J. L. Pereira, R. Spice | ||
| Vol 26, No 2 (2019) | Establishing funding rates for colonoscopy and gastroscopy procedures in Ontario | Abstract PDF HTML Supplemental Material |
| J. Monakova, J. Wong, I. Blais, A. Langan, N. Ratansi, D. Morgan, N. N. Baxter | ||
| Vol 26, No 2 (2019) | Estimating Health Care Costs of Non-Melanoma Skin Cancer in Saskatchewan using Physician Billing Data | Abstract PDF HTML |
| D. A. Tran, A. C. Coronado, S. Sarker, R. Alvi | ||
| Vol 23, No 3 (2016) | Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario | Abstract PDF HTML |
| J.H.E Yong, T. McGowan, R. Redmond-Misner, J. Beca, P. Warde, E. Gutierrez, J.S. Hoch | ||
| Vol 17, No 2 (2010) | Estimating the national wage loss from cancer in Canada | Abstract PDF |
| R. B. Hopkins, R. Goeree, C. J. Longo | ||
| Vol 23 (2016): Original Cancer Costing Research Using Canadian Data | Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada | Abstract PDF HTML |
| P.A. Tang, A.E. Hay, C.J. O’Callaghan, N. Mittmann, C.R. Chambers, J.L. Pater, N.B. Leighl | ||
| Vol 13, No 2 (2006) | ETHICAL GUIDEPOSTS TO CLINICAL TRIALS IN ONCOLOGY | Details PDF |
| Mark Bernstein | ||
| Vol 22, No 2 (2015) | Ethnicity and breast cancer stage at diagnosis: an issue of health equity | Abstract PDF HTML |
| A.K. Lofters | ||
| Vol 19, No 5 (2012) | Evaluating the efficacy of current clinical practice of adjuvant chemotherapy in postmenopausal women with early-stage, estrogen or progesterone receptor–positive, one-to-three positive axillary lymph node, breast cancer | Abstract PDF HTML |
| M.B. Hannouf, M. Brackstone, B. Xie, G.S. Zaric | ||
| Vol 17, No 4 (2010) | Evaluating the impact on quality of life of chemoradiation in gastric cancer | Abstract PDF |
| Z. Kassam, H. Mackay, C.A. Buckley, S. Fung, M. Pintilie, J. Kim, J. Ringash | ||
| Vol 20, No 1 (2013) | Evaluation of CancerChatCanada: a program of online support for Canadians affected by cancer | Abstract PDF HTML |
| J. Stephen, A. Rojubally, K. MacGregor, D. McLeod, M. Speca, J. Taylor-Brown, K. Fergus, K. Collie, J. Turner, S. Sellick, G. Mackenzie | ||
| Vol 17, No 2 (2010) | Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia | Abstract PDF |
| J. E. Corral, J. Quezada, E. J. Asturias | ||
| Vol 25, No 5 (2018) | Evaluation of subcutaneous rituximab administration on Canadian systemic therapy suites | Abstract PDF HTML |
| D. A. Stewart, J.S. Boudreault, B. Maturi, D. Boras, R. Foley | ||
| Vol 20, No 2 (2013) | Evaluation of the clinical benefits of nanoparticle albumin-bound paclitaxel in women with metastatic breast cancer in British Columbia | Abstract PDF HTML |
| A.E. Lohmann, C.H. Speers, S.K. Chia | ||
| Vol 25, No 4 (2018) | Evaluation of the delivery of survivorship care plans for South Asian female breast cancer survivors residing in Canada | Abstract PDF HTML |
| S. Singh-Carlson, F. Wong, G. Oshan | ||
| Vol 24, No 6 (2017) | Evidence in medicine: math versus biology! | Abstract PDF HTML |
| T. Younis, M. Thana, C. Skedgel | ||
| Vol 25, No 2 (2018) | Evidence-based best practices for EGFR T790M testing in lung cancer in Canada | Abstract PDF HTML |
| T. Stockley, C.A. Souza, P.K. Cheema, B. Melosky, S. Kamel-Reid, M.S. Tsao, A. Spatz, A. Karsan | ||
| Vol 21, No 3 (2014) | Evidence-based guidance on venous thromboembolism in patients with solid tumours | Abstract PDF HTML |
| M.A. Shea-Budgell, C.M.J. Wu, J.C. Easaw | ||
| Vol 21, No 2 (2014) | Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome–positive or BCR-ABL–positive acute lymphoblastic leukemia: a Canadian consensus | Abstract PDF HTML |
| S. Couban, L. Savoie, Y. Abou Mourad, B. Leber, M. Minden, R. Turner, V. Palada, N. Shehata, A. Christofides, S. Lachance | ||
| Vol 18, No 1 (2011) | Evidence-based medicine: an analysis of prophylactic bilateral oophorectomy at time of hysterectomy for benign conditions | Details PDF HTML |
| C. A. Larson | ||
| Vol 26, No 4 (2019) | Evolution of adolescent and young adult oncology in Canada | Abstract PDF HTML |
| S. DePauw, C. Rae, B. Schacter, P. Rogers, R. D. Barr | ||
| Vol 21, No 1 (2014) | Examining cancer-risk profiles for the largest metropolitan areas across Canada | Abstract PDF HTML |
| K. DeCaria, R. Rahal, T. Forte, G. Lockwood, J. Xu, H. Bryant, in collaboration with the System Performance Steering Committee and Technical Working Group | ||
| Vol 24, No 1 (2017) | Examining the medical resource utilization and costs of relapsed and refractory chronic lymphocytic leukemia in Ontario | Abstract PDF HTML |
| S. Hassan, S.J. Seung, M. C. Cheung, G. Fraser, B. Kuriakose, C. Trambitas, N. Mittmann | ||
| Vol 20, No 3 (2013) | Examining the use of salpingectomy with hysterectomy in Canada | Abstract PDF HTML |
| C. Sandoval, M. Fung-Kee-Fung, B. Gilks, K.J. Murphy, R. Rahal, H. Bryant | ||
| Vol 19, No 4 (2012) | Excision of the primary tumour in patients with metastatic breast cancer: a clinical dilemma | Abstract PDF HTML |
| S. Samiee, P. Berardi, N. Bouganim, L. Vandermeer, A. Arnaout, S. Dent, D. Mirsky, M. Chasen, J.M. Caudrelier, M. Clemons | ||
| Vol 20, No 4 (2013) | Exercise and nutrition interventions in advanced lung cancer: a systematic review | Abstract PDF HTML |
| C. Payne, P.J. Larkin, S. McIlfatrick, L. Dunwoody, J.H. Gracey | ||
| Vol 24, No 1 (2017) | Exercise for people with cancer: a clinical practice guideline | Abstract PDF HTML |
| R. Segal, C. Zwaal, E. Green, J.R. Tomasone, A. Loblaw, T. Petrella, The Exercise for People with Cancer Guideline Development Group | ||
| Vol 24, No 4 (2017) | Exercise for people with cancer: a systematic review | Abstract PDF HTML |
| R. Segal, C. Zwaal, E. Green, J. Tomasone, A. Loblaw, T. Petrella, the Exercise for People with Cancer Guideline Development Group | ||
| Vol 24, No 1 (2017) | Exercise guidelines for cancer survivors: are fitness and quality-of-life benefits enough to change practice? | Abstract PDF HTML |
| K.S. Courneya | ||
| Vol 19, No 3 (2012) | Exercise in clinical cancer care: a call to action and program development description | Abstract PDF HTML |
| D. Santa Mina, S.M.H. Alibhai, A.G. Matthew, C.L. Guglietti, J. Steele, J. Trachtenberg, P.G. Ritvo | ||
| Vol 16, No 3 (2009) | Exosomes in Tumour Immunity | Abstract PDF |
| Aled Clayton, M. D. Mason | ||
| Vol 24, No 4 (2017) | Experiences of Canadian oncologists with difficult patient deaths and coping strategies used | Abstract PDF HTML |
| L. Granek, L. Barbera, O. Nakash, M. Cohen, M.K. Krzyzanowska | ||
| Vol 21, No 1 (2014) | Exploring a “community of practice” methodology as a regional platform for large-scale collaboration in cancer surgery—the Ottawa approach | Abstract PDF HTML |
| M. Fung-Kee-Fung, R.P. Boushey, R. Morash | ||
| Vol 25, No 5 (2018) | Exploring cancer centres for physical activity and sedentary behaviour support for breast cancer survivors | Abstract PDF HTML |
| A. J. Fong, J. M. Jones, G. Faulkner, C. M. Sabiston | ||
| Vol 17, No 4 (2010) | Exploring cancer treatment decision-making by patients: a descriptive study | Abstract PDF |
| D. Stacey, L. Paquet, R. Samant | ||
| Vol 26, No 4 (2019) | Exploring reasons for overuse of contralateral prophylactic mastectomy in Canada | Abstract PDF HTML |
| J. E. Squires, S. N. Simard, S. Asad, D. Stacey, I. D. Graham, M. Coughlin, M. Clemons, J. M. Grimshaw, J. Zhang, J. M. Caudrelier, A. Arnaout | ||
| Vol 23, No 1 (2016) | Expression and clinical significance of insulin-like growth factor 1 in lung cancer tissues and perioperative circulation from patients with non-small-cell lung cancer | Abstract PDF HTML |
| S. Fu, H. Tang, Y. Liao, Q. Xu, C. Liu, Y. Deng, J. Wang, J. Wang, X. Fu | ||
| 501 - 600 of 1658 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
User
Current Oncology is published by:
Endorsed publication of the Canadian Association of Medical Oncologists (CAMO)
